Lamattina John L

Lamattina John L is listed in filings as Director at Ligand Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Jun 9, 2026, including sale activity. Recent filings connect the profile to Ligand Pharmaceuticals Inc (LGND). The current snapshot covers public activity from Jun 18, 2024 to Jun 9, 2026. Reported amounts are shown as $696.3K to $297.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.